Molecular Imaging Study of Harmine/DMT: a Basic Research Approach

NCT06252506 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
17
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Insel Gruppe AG, University Hospital Bern

Collaborators